Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STAG: AZD4017 for bone density in post-menopausal women
ISRCTN32813419Phase 2Completed
- Sponsor
- University of Leeds
- Start
- May 2015
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of AZD4017 in osteoporosis, sponsored by University of Leeds. Primary endpoint: Change from baseline in serum osteocalcin. Started May 2015; status: completed.
02
Drugs
AZD4017
03
Conditions
osteoporosis
Beyond the preview
Go deeper on ISRCTN32813419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN32813419.